Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What we don't know about avastin might hurt us.

× No keyword cloud information.

14 in total

Review 1. Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.

Authors: Taygan Yilmaz; Miguel Cordero-Coma
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2012-04-27 Impact factor: 3.117

Review 2. [Intravitreal injection. Monitoring to avoid postoperative complications].

Authors: C H Meyer; F Ziemssen; H Heimann
Journal: Ophthalmologe Date: 2008-02 Impact factor: 1.059

3. Comparison of intravitreal bevacizumab with macular photocoagulation for treatment of diabetic macular edema: a systemic review and Meta-analysis.

Authors: Xiang-Dong Liu; Xiao-Dong Zhou; Zhi Wang; Hong-Jie Shen
Journal: Int J Ophthalmol Date: 2014-12-18 Impact factor: 1.779

4. Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion.

Authors: Alireza Ramezani; Hamed Esfandiari; Morteza Entezari; Siamak Moradian; Masoud Soheilian; Babak Dehsarvi; Mehdi Yaseri
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2012-02-14 Impact factor: 3.117

5. Anti-VEGF (vascular endothelial growth factor) drugs in diabetic macular oedema.

Authors: J K Chhablani
Journal: Eye (Lond) Date: 2010-12-10 Impact factor: 3.775

Review 6. Meta-analysis and review on the effect of bevacizumab in diabetic macular edema.

Authors: Sunali Goyal; Michael Lavalley; Manju L Subramanian
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-07-28 Impact factor: 3.117

7. Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema.

Authors: G Querques; A V Bux; A R Fusco; C Iaculli; N Delle Noci
Journal: J Ophthalmol Date: 2010-03-09 Impact factor: 1.909

Review 8. Targeting vascular endothelial growth factor: a promising strategy for treating age-related macular degeneration.

Authors: Michael Waisbourd; Anat Loewenstein; Michaella Goldstein; Igal Leibovitch
Journal: Drugs Aging Date: 2007 Impact factor: 3.923

Review 9. Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors: Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal: Drugs Aging Date: 2009 Impact factor: 3.923

10. Off with the label and on the Avastin bandwagon: why now and how far?

Authors: K S Santhan Gopal
Journal: Indian J Ophthalmol Date: 2009 Jul-Aug Impact factor: 1.848